UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Investigational drugs in clinical trials for macular degeneration

Expert opinion on investigational drugs, 2022-10, Vol.31 (10), p.1067-1085

2022

Volltextzugriff (PDF)

Drugs in Phase II clinical trials for the treatment of age-related macular degeneration

Expert opinion on investigational drugs, 2015-02, Vol.24 (2), p.183-199

2015

Volltextzugriff (PDF)

Current and investigational drugs for the treatment of diabetic retinopathy

Expert opinion on investigational drugs, 2016-09, Vol.25 (9), p.1011-1022

2016

Volltextzugriff (PDF)

Current molecular understanding and future treatment strategies for pathologic ocular neovascularization

Current molecular medicine, 2009-11, Vol.9 (8), p.973-981

Tolentino, Michael J

2009

Volltextzugriff (PDF)

Challenges of selecting pharmacotherapy for macular edema the need for better and combination therapies

Expert opinion on pharmacotherapy, 2019-03, Vol.20 (4), p.373-377

2019

Volltextzugriff (PDF)

Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization

Retina (Philadelphia, Pa.), 2004-02, Vol.24 (1), p.132-138

2004

Volltextzugriff (PDF)

Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

JAMA ophthalmology, 2022-07, Vol.140 (7), p.692

2022

Volltextzugriff (PDF)

Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis

Ophthalmic surgery, lasers & imaging, 2007-03, Vol.38 (2), p.164-166

2007

Volltextzugriff (PDF)

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

JAMA ophthalmology, 2017-06, Vol.135 (6), p.639

2017

Volltextzugriff (PDF)

Pharmacological evidence for the role of RAR in axon guidance and embryonic development of a protostome species

Genesis (New York, N.Y. : 2000), 2019-07, Vol.57 (7-8), p.e23301-n/a

2019

Volltextzugriff (PDF)

Complications of Anti-Vascular Endothelial Growth Factor Drugs

Current drug therapy, 2012-01, Vol.7 (2), p.131-137

Tolentino, Michael

2012

Volltextzugriff (PDF)

Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT

Retina (Philadelphia, Pa.), 2003-06, Vol.23 (3), p.307-314

2003

Volltextzugriff (PDF)

Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration

Retina (Philadelphia, Pa.), 2002-12, Vol.22 (6), p.683

2002

Volltextzugriff (PDF)

Macular Supplements Containing Zinc and Vitamin A Should Be Replaced with Meso-Zeaxanthin, Lutein and Zeaxanthin: An Ophthalmic Need for Pharmacovigilance

Journal of Pharmacovigilance, 2016, Vol.4 (1)

2016

Volltextzugriff (PDF)

Transmission of retinal laser wavelengths through blood

Retina (Philadelphia, Pa.), 2005-06, Vol.25 (4), p.498-502

2005

Volltextzugriff (PDF)

SIGLECs the Main Self-Pattern Recognition Receptors of the Immune System. A Promising Target for Inflammatory Modulation

American Journal of Biomedical Science & Research, 2023-10, Vol.20 (3), p.360-365

Tolentino, Michael J

2023

Volltextzugriff (PDF)

Re: Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization

Retina (Philadelphia, Pa.), 2004-08, Vol.24 (4), p.661

2004

Volltextzugriff (PDF)

Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration

JAMA ophthalmology, 2013-12, Vol.131 (12), p.1595

2013

Volltextzugriff (PDF)

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

Archives of ophthalmology (1960), 1996-08, Vol.114 (8), p.964

1996

Volltextzugriff (PDF)

Central retinal vein occlusion immediately following cardiac surgery

Ophthalmic surgery, lasers & imaging, 2003-05, Vol.34 (3), p.215-216

2003

Volltextzugriff (PDF)

Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension Study

Ophthalmology retina, 2017-07, Vol.1 (4), p.304-313

2017

Volltextzugriff (PDF)

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6

Archives of ophthalmology (1960), 2009-09, Vol.127 (9), p.1115

2009

Volltextzugriff (PDF)

Interference RNA technology in the treatment of CNV

Ophthalmology clinics of North America, 2006-09, Vol.19 (3), p.393

Tolentino, Michael

2006

Volltextzugriff (PDF)

Clinical applications of color Doppler imaging in the management of orbital lesions

Ophthalmic plastic and reconstructive surgery, 2002-11, Vol.18 (6), p.462-465

2002

Volltextzugriff (PDF)

Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration

Ophthalmology retina, 2017-07, Vol.1 (4), p.304-313

2017

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionElektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

KollektionElsevier ScienceDirect Journals Complete

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(81)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Investigational drugs in clinical trials for macular degeneration

Drugs in Phase II clinical trials for the treatment of age-related macular degeneration

Current and investigational drugs for the treatment of diabetic retinopathy

Current molecular understanding and future treatment strategies for pathologic ocular neovascularization

Challenges of selecting pharmacotherapy for macular edema the need for better and combination therapies

Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization

Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

Pharmacological evidence for the role of RAR in axon guidance and embryonic development of a protostome species

Complications of Anti-Vascular Endothelial Growth Factor Drugs

Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT

Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration

Macular Supplements Containing Zinc and Vitamin A Should Be Replaced with Meso-Zeaxanthin, Lutein and Zeaxanthin: An Ophthalmic Need for Pharmacovigilance

Transmission of retinal laser wavelengths through blood

SIGLECs the Main Self-Pattern Recognition Receptors of the Immune System. A Promising Target for Inflammatory Modulation

Re: Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization

Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

Central retinal vein occlusion immediately following cardiac surgery

Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension Study

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6

Interference RNA technology in the treatment of CNV

Clinical applications of color Doppler imaging in the management of orbital lesions

Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration

Aktive Filter

Suchergebnisse filtern